NCT01969695View on ClinicalTrials.gov

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

December 20, 2013

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

ABT-199

ABT-199 continuous once daily dosing

Trial Locations (3)

85719-1478

University of Arizona Arthritis Center /ID# 101359, Tucson

03756

Dartmouth-Hitchcock Med Ctr /ID# 92596, Lebanon

07601

Hackensack Univ Med Ctr /ID# 101417, Hackensack

Sponsors

Lead Sponsor

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

AbbVie

INDUSTRY